Molecular genetic analysis of the APP, PSEN1, and PSEN2 genes in finnish patients with early-onset alzheimer disease and frontotemporal lobar degeneration

Alzheimer Disease and Associated Disorders

Volumn 26, Issue 3, 2012, Pages 272-276

  Krüger, Johanna ^a,b   Moilanen, Virpi ^a   Majamaa, Kari ^a,b   Remes, Anne M ^a,b  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Alzheimer disease; amyloid precursor protein; earlyonset dementia; frontotemporal lobar degeneration; genetics; mutation; polymorphism; presenilin

Indexed keywords

AMYLOID PRECURSOR PROTEIN; PRESENILIN 1; PRESENILIN 2;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; EARLY ONSET ALZHEIMER DISEASE; EXON; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; PRIORITY JOURNAL;

ADULT; AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; DNA MUTATIONAL ANALYSIS; FEMALE; FINLAND; FRONTOTEMPORAL LOBAR DEGENERATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PRESENILIN-1; PRESENILIN-2;

EID: 84865778634     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e318231e6c7     Document Type: Article

References (46)

1. Rocca WA, Hofman A, Brayne C, et al. Frequency and distribution of Alzheimer's disease in Europe: A collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group. Ann Neurol. 1991; 30:381-390.
2. Campion D, Dumanchin C, Hannequin D, et al. Early-onset autosomal dominant Alzheimer disease: Prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet. 1999; 65:664-670.
3. Goate A, Chartier-Harlin MC, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991;349: 704-706.
4. Schellenberg GD, Bird TD, Wijsman EM, et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science. 1992;258:668-671.
5. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 1995;375:754-760.
6. Levy-Lahad E, Wasco W, Poorkaj P, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 1995;269:973-977.
7. Rogaev EI, Sherrington R, Rogaeva EA, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 1995;376:775-778.
8. Cruts M, van Duijn CM, Backhovens H, et al. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet. 1998;7:43-51.
9. AD mutation database; http://www.molgen.ua.ac.be/ADMutations/.
10. Rovelet-Lecrux A, Hannequin D, Raux G, et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet. 2006; 38:24-26.
11. Sleegers K, Brouwers N, Gijselinck I, et al. APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. Brain. 2006;129:2977-2983.
12. Rovelet-Lecrux A, Frebourg T, Tuominen H, et al. APP locus duplication in a Finnish family with dementia and intracerebral haemorrhage. J Neurol Neurosurg Psychiatry. 2007;78: 1158-1159.
13. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921-923.
14. Van Duijn CM, de Knijff P, Cruts M, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet. 1994;7:74-78.
15. Tedde A, Forleo P, Nacmias B, et al. A presenilin-1 mutation (Leu392Pro) in a familial AD kindred with psychiatric symptoms at onset. Neurology. 2000;55:1590-1591.
16. Raux G, Gantier R, Thomas-Anterion C, et al. Dementia with prominent frontotemporal features associated with L113P presenilin 1 mutation. Neurology. 2000;55:1577-1579.
17. Dermaut B, Kumar-Singh S, Engelborghs S, et al. A novel presenilin 1 mutation associated with Pick's disease but not beta-amyloid plaques. Ann Neurol. 2004;55:617-626.
18. Bernardi L, Tomaino C, Anfossi M, et al. Novel PSEN1 and PGRN mutations in early-onset familial frontotemporal dementia. Neurobiol Aging. 2009;30:1825-1833.
19. Gallo M, Tomaino C, Puccio G, et al. Novel MAPT Val75Ala mutation and PSEN2 Arg62Hys in two siblings with frontotemporal dementia. Neurol Sci. 2010;31:65-70.
20. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34:939-944.
21. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology. 1998;51:1546-1554.
22. Kaivorinne AL, Krü ger J, Kuivaniemi K, et al. Role of MAPT mutations and haplotype in frontotemporal lobar degeneration in Northern Finland. BMC Neurol. 2008;8:48.
23. Krü ger J, Kaivorinne AL, Majamaa K, et al. Low prevalence of progranulin mutations in Finnish patients with frontotemporal lobar degeneration. Eur J Neurol. 2009;16:27-30.
24. Remes AM, Finnilä S, Mononen H, et al. Hereditary dementia with intracerebral hemorrhages and cerebral amyloid angiopathy. Neurology. 2004;63:234-240.
25. Prihar G, Verkkoniemi A, Perez-Tur J, et al. Alzheimer disease PS-1 exon 9 deletion defined. Nat Med. 1999;5:1090.
26. Helisalmi S, Hiltunen M, Mannermaa A, et al. Is the presenilin-1 E318G missense mutation a risk factor for Alzheimer's disease? Neurosci Lett. 2000;278:65-68.
27. Wenham PR, Price WH, Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 1991;337:1158-1159.
28. Sandbrink R, Zhang D, Schaeffer S, et al. Missense mutations of the PS-1/S182 gene in German early-onset Alzheimer's disease patients. Ann Neurol. 1996;40:265-266.
29. Dermaut B, Cruts M, Slooter AJ, et al. The Glu318Gly substitution in presenilin 1 is not causally related to Alzheimer disease. Am J Hum Genet. 1999;64:290-292.
30. Zekanowski C, Pepoń ska B, Styczyń ska M, et al. The E318G substitution in PSEN1 gene is not connected with Alzheimer's disease in a large Polish cohort. Neurosci Lett. 2004;357:167-170.
31. Sleegers K, Roks G, Theuns J, et al. Familial clustering and genetic risk for dementia in a genetically isolated Dutch population. Brain. 2004;127:1641-1649.
32. Guerreiro RJ, Baquero M, Blesa R, et al. Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP. Neurobiol Aging. 2008;31:725-731.
33. Blom ES, Viswanathan J, Kilander L, et al. Low prevalence of APP duplications in Swedish and Finnish patients with earlyonset Alzheimer's disease. Eur J Hum Genet. 2008;16:171-175.
34. Crook R, Verkkoniemi A, Perez-Tur J, et al. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat Med. 1998;4:452-455.
35. Hiltunen M, Helisalmi S, Mannermaa A, et al. Identification of a novel 4.6-kb genomic deletion in presenilin-1 gene which results in exclusion of exon 9 in a Finnish early onset Alzheimer's disease family: An Alu core sequence-stimulated recombination? Eur J Hum Genet. 2000;8:259-266.
36. Martikainen P, Pikkarainen M, Pö ntynen K, et al. Brain pathology in three subjects from the same pedigree with presenilin-1 (PSEN1) P264L mutation. Neuropathol Appl Neurobiol. 2010;36:41-54.
37. Haltia M, Viitanen M, Sulkava R, et al. Chromosome 14-encoded Alzheimer's disease: Genetic and clinicopathological description. Ann Neurol. 1994;36:362-367.
38. Clark RF, Hutton M, Fuldner M, et al. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Alzheimer's Disease Collaborative Group. Nat Genet. 1995;11:219-222.
39. Janssen JC, Beck JA, Campbell TA, et al. Early onset familial Alzheimer's disease: Mutation frequency in 31 families. Neurology. 2003;60:235-239.
40. Piscopo P, Manfredi A, Malvezzi-Campeggi L, et al. Genetic study of Sardinian patients with Alzheimer's disease. Neurosci Lett. 2006;398:124-128.
41. Norio R, Nevanlinna HR, Perheentupa J. Hereditary diseases in Finland; rare flora in rare soul. Ann Clin Res. 1973;5:109-141.
42. Taddei K, Fisher C, Laws SM, et al. Association between presenilin-1 Glu318Gly mutation and familial Alzheimer's disease in the Australian population. Mol Psychiatry. 2002; 7:776-781.
43. Albani D, Roiter I, Artuso V, et al. Presenilin-1 mutation E318G and familial Alzheimer's disease in the Italian population. Neurobiol Aging. 2007;28:1682-1688.
44. St.George-Hyslop P, McLachlan DC, Tsuda T, et al. Alzheimer's disease and possible gene interaction. Science. 1994;263:537.
45. Van Broeckhoven C, Backhovens H, Cruts M, et al. APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease. Neurosci Lett. 2004;169:179-180.
46. Wijsman EM, Daw EW, Yu X, et al. APOE and other loci affect age-at-onset in Alzheimer's disease families with PS2 mutation. Am J Med Genet B Neuropsychiatr Genet. 2005; 132B:14-20.